GordonMD® Global Investments LP announced today that its portfolio company, Flare Therapeutics Inc., has entered into a strategic discovery collaboration with Roche (SIX: RO, ROG; OTCQX: RHHBY). Flare ...

Roche Holding saw its EPS decline at a compound rate of 6.7% per year, over the last three years. This reduction in EPS is ...

Roche launched the "Digital Healthcare Incubator 2.0" at the seventh China International Import Expo in Shanghai. [Photo ...

Alongside opening the new offices, Roche Diagnostics capabilities in China have been further recognised as it has been ...

In its third-quarter 2024 financial results, Synlogic reported no revenue, down from $0.4 million during the same period last year, which was attributed to a previous collaboration with Roche. The ...

In a report released today, Matthew Weston from UBS maintained a Hold rating on Roche Holding AG (RHHVF – Research Report), with a price target of CHF270.00. The company’s shares closed yesterday at ...

The first shipment of FDA-approved cervical screening self-tests has gone out with hopes they will help prevent cervical ...

Roche Bros. has 20 supermarkets in the Boston area and experts say having a Connecticut distributor as majority owner could bring the grocer here.

Merck's undervalued stock presents growth opportunities with Keytruda and promising pipeline drugs, making it a Buy despite ...

Roche’s Genentech is ending a partnership with Nykode Therapeutics that centered around a clinical-stage cancer vaccine ...

Nov. 12, 2024 /PRNewswire/ -- Flare Therapeutics Inc., a clinical-stage biotechnology company targeting transcription factors ...